60 DEGREES PHARMACEUTICALS, INC. Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD for Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
60 Degrees Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate for Q4 2023.
  • 60 Degrees Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2023 was $699K.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $699K Dec 31, 2023 10-K 2024-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.